Pfizer Inc. (PFE)

Pfizer Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	157,596	141,574	150,345	162,560	287,626	331,440
Market Cap Growth	12.91%	-5.83%	-7.51%	-43.48%	-13.22%	61.99%
Enterprise Value	209,372	188,821	208,609	182,781	288,752	341,892
Last Close Price	27.78	23.68	23.53	24.06	40.96	45.72

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	36.52	18.22	18.72	76.72	9.17	15.08
Forward PE	10.03	8.54	9.91	19.25	10.82	10.64
PS Ratio	2.47	2.26	2.36	2.73	2.84	4.08
PB Ratio	1.86	1.63	1.70	1.82	3.00	4.28
P/TBV Ratio	-	-	-	-	314.00	116.42
P/FCF Ratio	14.30	15.60	15.29	33.92	11.05	11.10
P/OCF Ratio	11.72	12.10	11.80	18.68	9.83	10.17
PEG Ratio	-	29.47	1.27	1.32	5.15	1.00

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	3.28	3.02	3.28	3.07	2.85	4.21
EV/EBITDA Ratio	8.23	7.34	9.25	14.54	6.44	10.66
EV/EBIT Ratio	11.09	9.85	13.41	28.94	7.25	12.67
EV/FCF Ratio	19.02	20.81	21.21	38.14	11.09	11.45

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.74	0.78	0.76	0.84	0.41	0.53
Debt / EBITDA Ratio	2.41	2.54	2.84	5.44	0.85	1.26
Debt / FCF Ratio	5.78	7.45	6.86	15.72	1.51	1.39
Net Debt / Equity Ratio	0.61	0.62	0.53	0.70	0.17	0.13
Net Debt / EBITDA Ratio	2.04	2.10	2.08	4.98	0.37	0.32
Net Debt / FCF Ratio	4.71	5.96	4.77	13.07	0.64	0.35
Asset Turnover	0.31	0.30	0.29	0.28	0.53	0.48
Inventory Turnover	1.49	1.41	1.63	2.50	3.78	3.59
Quick Ratio	0.85	0.80	0.82	0.59	0.88	1.10
Current Ratio	1.27	1.16	1.17	0.91	1.22	1.40
Return on Equity (ROE)	5.01%	8.89%	9.06%	2.35%	36.22%	31.87%
Return on Assets (ROA)	5.78%	5.68%	4.42%	1.86%	13.15%	10.05%
Return on Invested Capital (ROIC)	13.49%	13.87%	10.83%	4.78%	35.96%	27.65%
Return on Capital Employed (ROCE)	11.20%	11.20%	9.10%	3.50%	25.70%	19.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	2.76%	5.49%	5.34%	1.30%	10.91%	6.63%
FCF Yield	6.99%	6.41%	6.54%	2.95%	9.05%	9.01%
Dividend Yield	6.22%	7.26%	7.14%	6.82%	3.91%	3.41%
Payout Ratio	226.35%	125.74%	118.44%	436.39%	28.63%	39.72%
Buyback Yield / Dilution	-0.34%	-0.23%	0.16%	0.42%	-0.44%	-1.35%
Total Shareholder Return	5.90%	7.04%	7.30%	7.24%	3.47%	2.06%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error